LIFE EDIT
Live / Registered — Registered (as of 08 Nov 2022)
What this means for you
Registered since 08 Nov 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90680188
- Registration number
- 6896646
- Mark type
- Design + words
- Filed
- 29 Apr 2021
- Published for opposition
- 03 May 2022
- Registered
- 08 Nov 2022
- Attorney of record
- Maury M. Tepper
Goods and services
- Class 001 — Chemicals: Genome engineering reagents; genome editing and amplification reagents
- Class 042 — Scientific and technological services: Genome engineering services; scientific analysis services in the field of genome editing; scientific research in the fields of biotechnology, cellular engineering, and genome engineering; genome editing and amplification; scientific study and research in the field of cellular engineering and genome modification
- Class 045 — Legal and security services: Licensing of intellectual property in the fields of biotechnology and genome engineering
Owner
- LIFE EDIT THERAPEUTICS, INC., DURHAM, NC, US
- Lifeedit Therapeutics, Inc., Morrisville, NC, US
- Lifeedit Therapeutics, Inc., Morrisville, NC, US
- Lifeedit Therapeutics, Inc., Durham, NC, US
Prosecution history
- 30 Oct 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 08 Nov 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Nov 2022 — REGISTERED-PRINCIPAL REGISTER
- 04 Oct 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Oct 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Sept 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Aug 2022 — USE AMENDMENT FILED
- 01 Sept 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Aug 2022 — TEAS STATEMENT OF USE RECEIVED
- 28 Jun 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 May 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 May 2022 — PUBLISHED FOR OPPOSITION
- 13 Apr 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Mar 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Mar 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED